Immunize.org supports evidence-based vaccination recommendations and schedules. Read more at About Us.

Healthcare Professional Organization Vaccine Recommendations

Some healthcare professional organizations develop and publish recommendations for the use of vaccines or passive immunizations for the population they serve. Use the search tools below to locate current recommendations available from these organizations.

Results (22)
  • RSV (Respiratory Syncytial Virus)
Current
ACOG Practice Advisory — Maternal Respiratory Syncytial Virus Vaccination
This Practice Advisory provides guidance for the use of respiratory syncytial virus (RSV) vaccine during pregnancy for the prevention of severe RSV disease in young infants.
9/2/2026. ACOG Practice Advisory
The American College of Obstetricians and Gynecologists (ACOG) develops and promotes clinical guidance for safe and effective vaccination of pregnant and reproductive-age patients.
Read at American College of Obstetricians and Gynecologists (ACOG)
  • Influenza
Current
ACOG Practice Advisory — Influenza in Pregnancy: Prevention and Treatment
This Practice Advisory provides an overview of guidance for the use of the annual influenza vaccine in prepregnant, pregnant, postpartum, and lactating individuals for the prevention of influenza infection and, particularly, the severe complications associated with it in pregnant people.
9/2/2026. ACOG Practice Advisory
The American College of Obstetricians and Gynecologists (ACOG) develops and promotes clinical guidance for safe and effective vaccination of pregnant and reproductive-age patients.
Read at American College of Obstetricians and Gynecologists (ACOG)
  • COVID-19
Current
AAP Recommendations for COVID-19 Vaccines in Infants, Children, and Adolescents, 2026-2027: Policy Statement
This policy statement updates the recommendations of the AAP for the use of coronavirus disease 2019 (COVID-19) vaccines in the prevention of severe COVID-19 in children.
9/2/2026. Pediatrics (2026) doi.org/10.1542/peds.2026-079046
The American Academy of Pediatrics (AAP) is a leading professional organization that develops evidence-based immunization policy and clinical guidance to protect the health of infants, children, and adolescents. AAP supports pediatric clinicians with education, tools, and advocacy to improve vaccination coverage and safety. The PDF is linked to the companion article from AAP, published as Recommendations for COVID-19 Vaccines in Infants, Children, and Adolescents, 2026-2027: Technical Report.
Read at American Academy of Pediatrics (AAP)
View PDF
  • COVID-19
  • Influenza
  • RSV (Respiratory Syncytial Virus)
Current
IDSA 2026 Guidelines on the Use of Vaccines for the Prevention of Seasonal COVID-19, Influenza, and RSV Infections in Immunocompromised Patients
To support evidence-based clinical & shared decision-making during the 2026-2027 respiratory tract infection season, IDSA developed updated evidence and guidelines for the use of U.S-licensed vaccine against COVID-19, Influenza, and RSV in adult and pediatric patients who are immunocompromised.
9/2/2026. IDSA Practice Advisory
The Infectious Diseases Society of America (IDSA) develops evidence-based immunization policy and recommendations to prevent infectious diseases across populations. Its recommendations include immunocompromised patients.
Read at Infectious Diseases Society of America (IDSA)
  • RSV (Respiratory Syncytial Virus)
Current
AAP Recommendations for the Prevention of RSV Disease in Infants and Children: Policy Statement
This policy statement updates recommendations of the American Academy of Pediatrics (AAP) for the use of respiratory syncytial virus (RSV) immunization for the prevention of lower respiratory tract infection (LRTI) caused by RSV in infants and children. The AAP recommends RSV immunization for all infants under 8 months of age born during or entering their first RSV season, unless the infant has documented protection from vaccination of their pregnant parent; and for infants and children 8 through 19 months of age who are at high risk of severe RSV disease and entering their second RSV season. The PDF is linked to the companion article from AAP, published as Recommendations for Prevention of Respiratory Syncytial Virus Disease in Infants and Children: Technical Report.
9/2/2026. Pediatrics (2026), DOI: 10.1542/peds.2026-079047
The American Academy of Pediatrics (AAP) is a leading professional organization that develops evidence-based immunization policy and clinical guidance to protect the health of infants, children, and adolescents. AAP supports pediatric clinicians with education, tools, and advocacy to improve vaccination coverage and safety.
Read at American Academy of Pediatrics (AAP)
View PDF
  • COVID-19
  • Influenza
  • RSV (Respiratory Syncytial Virus)
Current
AAFP Fall 2026 Immunization Recommendations
The AAFP has released their fall immunization recommendations, reinforcing a commitment to the health of communities across the country. The AAFP urges all adults, children and families to stay up to date on recommended vaccines to keep themselves and their loved ones healthy.
9/2/2026. AAFP Recommendation Statement.
The AAFP is the largest national association of family physicians and supports evidence-based immunization practices for patients of all ages.
  • COVID-19
Current
ACOG Practice Advisory — COVID-19 Vaccination Considerations for Obstetric–Gynecologic Care
This Practice Advisory provides an overview of the currently available COVID-19 vaccines and guidance for their use in individuals contemplating pregnancy and in pregnant, recently pregnant, and lactating individuals.
9/2/2026. ACOG Practice Advisory
The American College of Obstetricians and Gynecologists (ACOG) develops and promotes clinical guidance for safe and effective vaccination of pregnant and reproductive-age patients.
Read at American College of Obstetricians and Gynecologists (ACOG)
  • Influenza
Current
AAP Recommendations for Prevention and Control of Influenza in Children, 2026–2027: Policy Statement
This policy statement updates the recommendations of the American Academy of Pediatrics (AAP) for the use of influenza vaccines and antiviral medications in the prevention and treatment of influenza in children during the 2026–2027 influenza season. Part 2 is linked to the companion article from AAP, published as Recommendations for Prevention and Control of Influenza in Children, 2026–2027: Technical Report.
8/10/2026. Pediatrics (2026), DOI: 10.1542/peds.2026-078778
The American Academy of Pediatrics (AAP) is a leading professional organization that develops evidence-based immunization policy and clinical guidance to protect the health of infants, children, and adolescents. AAP supports pediatric clinicians with education, tools, and advocacy to improve vaccination coverage and safety.
View PDF
  • RSV (Respiratory Syncytial Virus)
Current
Respiratory Syncytial Virus Vaccines in Adults Who Are Not Pregnant or Immunocompromised: Rapid Practice Points From the American College of Physicians
The American College of Physicians (ACP) developed these rapid practice points addressing the efficacy, comparative effectiveness, and harms of respiratory syncytial virus (RSV) vaccines in adults aged 18 years or older who are not pregnant or immunocompromised.
3/6/2026. Annals of Internal Medicine; DOI:10.7326/ANNALS-25-05026
The American College of Physicians (ACP) develops evidence-based adult immunization and provides clinical guidance to help internists incorporate vaccines into routine care of adults.
Read at American College of Physicians (ACP)
  • COVID-19
Current
COVID-19 Vaccines for 2025–2026 in Adults Who Are Not Pregnant or Immunocompromised: Rapid Practice Points from the American College of Physicians
ACP developed these rapid practice points addressing the comparative effectiveness and harms of Omicron-adapted COVID-19 vaccines in adults aged 18 years or older who are not pregnant or immunocompromised.
2/24/2026. Annals of Internal Medicine; DOI:10.7326/ANNALS-25-05026
The American College of Physicians (ACP) develops evidence-based adult immunization and provides clinical guidance to help internists incorporate vaccines into routine care of adults.
Read at American College of Physicians (ACP)
  • Influenza
Current
Influenza Vaccines for 2025–2026 in Adults Who Are Not Pregnant or Immunocompromised: Rapid Practice Points From the American College of Physicians
ACP developed these rapid practice points addressing the comparative effectiveness and harms of influenza vaccines in adults aged 18 years or older who are not pregnant or immunocompromised. These practice points do not address adults aged 18 years or older who are pregnant or immunocompromised.
11/18/2025. Annals of Internal Medicine; DOI:10.7326/ANNALS-25-04056
The American College of Physicians (ACP) develops evidence-based adult immunization and provides clinical guidance to help internists incorporate vaccines into routine care of adults.
Read at American College of Physicians (ACP)
  • COVID-19
  • Influenza
  • RSV (Respiratory Syncytial Virus)
Archived
IDSA 2025 Guidelines on the Use of Vaccines for the Prevention of Seasonal COVID-19, Influenza, and RSV Infections in Immunocompromised Patients
To support evidence-based clinical & shared decision-making during the 2025-2026 respiratory tract infection season, IDSA developed rapid guidelines for the use of U.S-licensed vaccine against COVID-19, Influenza, and RSV in adult and pediatric patients who are immunocompromised.
11/18/2025. IDSA Practice Advisory
The Infectious Diseases Society of America (IDSA) develops evidence-based immunization policy and recommendations to prevent infectious diseases across populations. Its recommendations include immunocompromised patients.
Read at Infectious Diseases Society of America (IDSA)
  • RSV (Respiratory Syncytial Virus)
Archived
AAP Recommendations for the Prevention of RSV Disease in Infants and Children: Policy Statement
The American Academy of Pediatrics (AAP) recommendations for respiratory syncytial virus (RSV) immunization for infants <8 months of age born during or entering their first RSV season and infants and children 8 through 19 months of age at high risk of severe RSV disease and entering their second RSV season.
10/20/2025. Pediatrics (2025) 156 (5): e2025073923.
The American Academy of Pediatrics (AAP) is a leading professional organization that develops evidence-based immunization policy and clinical guidance to protect the health of infants, children, and adolescents. AAP supports pediatric clinicians with education, tools, and advocacy to improve vaccination coverage and safety.
Read at American Academy of Pediatrics (AAP)
View PDF
  • COVID-19
Archived
AAP Recommendations for COVID-19 Vaccines in Infants, Children, and Adolescents: Policy Statement
This policy statement updates the recommendations of the AAP for the use of coronavirus disease 2019 (COVID-19) vaccines in the prevention of severe COVID-19 in children.
10/20/2025. Pediatrics; doi: 10.1542/peds.2025-073924
The American Academy of Pediatrics (AAP) is a leading professional organization that develops evidence-based immunization policy and clinical guidance to protect the health of infants, children, and adolescents. AAP supports pediatric clinicians with education, tools, and advocacy to improve vaccination coverage and safety.
Read at American Academy of Pediatrics (AAP)
View PDF
  • COVID-19
Current
PALTmed Recommendations for COVID-19 Vaccine in Post-Acute and Long-Term Care Residents and Staff
PALTmed’s Infection Advisory Committee has developed recommendations for the 2025–2026 COVID-19 vaccine to guide clinicians and administrators in post-acute and long-term care settings.
10/14/2025. JAMDA; DOI: 10.1016/j.jamda.2025.106002
The Post-Acute and Long-Term Care Medical Association (PALTmed) promotes immunization policies and recommendations to protect residents and staff in post-acute and long-term care settings.
Read at Post-Acute and Long-Term Care Medical Association (PALTmed)
View PDF
  • COVID-19
Archived
ACOG Practice Advisory — COVID-19 Vaccination Considerations for Obstetric–Gynecologic Care
This Practice Advisory provides an overview of the currently available COVID-19 vaccines and guidance for their use in individuals contemplating pregnancy and in pregnant, recently pregnant, and lactating individuals.
10/2025. ACOG Practice Advisory
The American College of Obstetricians and Gynecologists (ACOG) develops and promotes clinical guidance for safe and effective vaccination of pregnant and reproductive-age patients.
Read at American College of Obstetricians and Gynecologists (ACOG)
  • RSV (Respiratory Syncytial Virus)
Archived
ACOG Practice Advisory — Maternal Respiratory Syncytial Virus Vaccination
This Practice Advisory provides guidance for the use of respiratory syncytial virus (RSV) vaccine during pregnancy for the prevention of severe RSV disease in young infants.
10/2025. ACOG Practice Advisory
The American College of Obstetricians and Gynecologists (ACOG) develops and promotes clinical guidance for safe and effective vaccination of pregnant and reproductive-age patients.
Read at American College of Obstetricians and Gynecologists (ACOG)
  • Influenza
Archived
ACOG Practice Advisory — Influenza in Pregnancy: Prevention and Treatment
This Practice Advisory provides an overview of guidance for the use of the annual influenza vaccine in prepregnant, pregnant, postpartum, and lactating individuals for the prevention of influenza infection and, particularly, the severe complications associated with it in pregnant people.
10/2025. ACOG Practice Advisory
The American College of Obstetricians and Gynecologists (ACOG) develops and promotes clinical guidance for safe and effective vaccination of pregnant and reproductive-age patients.
Read at American College of Obstetricians and Gynecologists (ACOG)
  • Influenza
Archived
AAP Recommendations for Prevention and Control of Influenza in Children, 2025–2026: Policy Statement
This statement updates the recommendations of the American Academy of Pediatrics (AAP) for the use of influenza vaccines and antiviral medications in the prevention and treatment of influenza in children during the 2025–2026 influenza season.
9/22/2025. Pediatrics (2025) 156 (6): e2025073620.
The American Academy of Pediatrics (AAP) is a leading professional organization that develops evidence-based immunization policy and clinical guidance to protect the health of infants, children, and adolescents. AAP supports pediatric clinicians with education, tools, and advocacy to improve vaccination coverage and safety.
Read at American Academy of Pediatrics (AAP)
View PDF
  • COVID-19
  • Influenza
  • RSV (Respiratory Syncytial Virus)
Archived
AAFP Fall 2025 Immunization Recommendations
The AAFP has released their fall immunization recommendations, reinforcing a commitment to the health of communities across the country. The AAFP urges all adults, children and families to stay up to date on recommended vaccines to keep themselves and their loved ones healthy.
9/8/2025. AAFP Recommendation Statement.
The AAFP is the largest national association of family physicians and supports evidence-based immunization practices for patients of all ages.
  • COVID-19
Current
SHEA Reaffirms Support for COVID-19 Vaccination Among Healthcare Personnel, Including Pregnant Staff
SHEA supports healthcare personnel (HCP), including pregnant HCP, to be free to choose to continue to get vaccinated against COVID-19 to protect them and their patients from the COVID-19 virus.
5/28/2025. The Society for Healthcare Epidemiology of America
The Society for Healthcare Epidemiology of America (SHEA) develops immunization recommendations to prevent healthcare-associated infections and protect both patients and healthcare personnel.
Read at Society for Healthcare Epidemiology of America (SHEA)
  • Influenza
Current
Revised SHEA Position Paper: Influenza Vaccination of Healthcare Personnel
SHEA views influenza vaccination of healthcare personnel as a core patient and healthcare personnel safety practice.  This recommendation applies to all healthcare personnel working in all healthcare settings, regardless of whether they have direct patient contact or whether they are directly employed by the facility. It also applies to all students, volunteers, and contract workers. Read at https://shea-online.org/guidance/revised-shea-position-paper-influenza-vaccination-of-healthcare-personnel/

October 2010, Infection Control & Hospital Epidemiology, Volume 31, Issue 10, pp. 987 - 995
The Society for Healthcare Epidemiology of America (SHEA) develops immunization recommendations to prevent healthcare-associated infections and protect both patients and healthcare personnel.
Read at Society for Healthcare Epidemiology of America (SHEA)

This page was updated on .

Our Affiliated Sites

For the Public: VaccineInformation.org
For Coalitions: ImmunizationCoalitions.org
Let's Get Real
Information about pediatric vaccines for parents and providers.
65+ Flu Defense
Protect vulnerable, older adult patients from influenza.
Give2MenACWY.org
Improve protection from meningococcal serogroups ACWY.
NAIIS
Home of the National Adult and Influenza Immunization Summit.